Caplin Point Laboratories Limited's step-down subsidiary, Triwin Pharma S.A DE C.V, Mexico had acquired land measuring approximately 5.5 acres located at Municipality of Capulhuac, District of Tenango Del Valle, state of Mexico for the purpose of setting up a manufacturing facility.

In the initial phase, the unit will have the facility to manufacture Suppositories, Topicals and other products. Initial capacity expected to be 50 million units per annum.

The investment in land is Rs. 19.85 crore and the proposed investment in setting up the manufacturing facility is up to Rs. 133 crore.

The facility is targeted to be commissioned during FY 2027.